Age-related differences in human skin proteoglycans. (1/3)
(+info)Expression and the role of 3'-phosphoadenosine 5'-phosphosulfate transporters in human colorectal carcinoma. (2/3)
(+info)Removal of sulfa drugs by sewage treatment in aqueous solution systems: activated carbon treatment and ozone oxidation. (3/3)
This study investigates the activated carbon (AC) treatment and ozone oxidation of the sulfa drugs--sulfamethoxazole (SMX), sulfamonomethoxine (SMM), sulfadimidine (SDD), and sulfadimethoxine (SDM)--in aqueous solution systems. Three AC samples were prepared from Shirasagi (AC1 and AC2) and coal (AC3), and the surface functional groups, solution pH, specific surface areas, pore volumes, and morphologies of the three samples were evaluated. The specific surface areas were in the following order: AC1 (1391 m(2)/g) > AC2 (1053 m(2)/g) > AC3 (807 m(2)/g). The pore volume and mean pore diameter of AC3 were greater than those of AC1 and AC2. The concentration of sulfa drugs adsorbed onto the AC samples reached equilibrium within 150 h. Experimental data of the adsorption rate were fitted to a pseudo-second-order model. The amount of sulfa drugs adsorbed onto the AC samples was in the order of SDM < SMM < SDD < SMX; the mechanism of adsorption of the sulfa drugs onto the AC samples depended on the hydrophobicity of the AC surface. The adsorption isotherm data were fitted to Freundlich and Langmuir models. Ozone was generated from oxygen gas using an A-27 ozone generator, and the complete degradation of the sulfa drugs by ozone treatment at 60 mL/min was achieved within 50 min. Ozone treatment caused the structure of the sulfa drugs to decompose via ozone oxidation. (+info)Sulfamonomethoxine is a type of antibiotic known as a sulfonamide, which is used to treat various bacterial infections. It works by interfering with the ability of bacteria to produce folic acid, an essential component for their growth and survival. By doing so, it inhibits the growth and multiplication of susceptible bacteria.
Sulfamonomethoxine is often prescribed to treat urinary tract infections, respiratory infections, and other bacterial infections. It is available in oral form and is typically administered in combination with trimethoprim, another antibiotic, as a fixed-dose combination therapy known as co-trimoxazole or sulfamethoxazole-trimethoprim.
It's important to note that the use of sulfonamides like sulfamonomethoxine can cause side effects such as rash, nausea, vomiting, and headache. In rare cases, it may also lead to severe adverse reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis. Therefore, it should only be used under the supervision of a healthcare provider who can monitor for potential side effects and adjust the treatment accordingly.